C83.31 Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck

Name of the Condition

• Diffuse Large B-Cell Lymphoma, Lymph Nodes of Head, Face, and Neck (ICD-10 Code: C83.31)

Summary

Diffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma that originates in B-cells, a type of white blood cell. It is characterized by rapidly growing tumors in the lymph nodes or other lymphoid tissues. This code specifies involvement of the lymph nodes in the head, face, and neck region. DLBCL is one of the most common subtypes of non-Hodgkin lymphoma and can occur in various parts of the body.

Causes

The exact cause of DLBCL is not fully understood. It is believed to result from genetic mutations in B-cells, which may be triggered by factors such as previous infections (e.g., Epstein-Barr virus), immune system dysfunctions, or exposure to certain environmental agents. These mutations disrupt normal cell growth and division, leading to uncontrolled proliferation.

Risk Factors

• Advanced age (most common in older adults)
• Weakened immune system (e.g., from HIV, organ transplants, or immunosuppressive drugs)
• Family history of lymphoma
• Exposure to certain chemicals or radiation
• Chronic infections (e.g., hepatitis C)

Symptoms

• Swollen, painless lymph nodes in the head, face, or neck
• Unexplained weight loss
• Fever
• Night sweats
• Fatigue
• Loss of appetite
• Difficulty swallowing or breathing (if lymph nodes compress nearby structures)

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT or PET scans) to assess lymph node involvement, and a biopsy of the affected lymph node. Blood tests may also be performed to evaluate overall health and detect abnormalities. Pathological analysis of the biopsy confirms the presence of DLBCL and helps determine the specific subtype.

Treatment Options

• Chemotherapy: Often the primary treatment, targeting rapidly dividing cancer cells.
• Immunotherapy: Drugs like rituximab enhance the immune system's ability to attack cancer cells.
• Radiation therapy: May be used to target localized lymph node involvement.
• Stem cell transplant: Considered for relapsed or high-risk cases.

Prognosis and Follow-Up

Prognosis depends on factors such as age, overall health, and response to treatment. Many patients achieve remission with standard therapy, but regular follow-up is essential to monitor for recurrence. Follow-up typically includes periodic imaging and blood tests.

Complications

• Tumor lysis syndrome (due to rapid cell death during treatment)
• Infection risk from weakened immune system
• Organ damage from lymph node compression
• Relapse of lymphoma

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid exposure to known carcinogens (e.g., certain chemicals, radiation).
• Manage chronic infections promptly.
• Discuss family history of lymphoma with a healthcare provider.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or other symptoms listed above. Early diagnosis improves treatment outcomes.

Tips for Medical Coders

Use code C83.31 for diffuse large B-cell lymphoma specifically involving the lymph nodes of the head, face, and neck. Ensure documentation supports the anatomical location to justify this code. Verify that the diagnosis aligns with the clinical findings and that no more specific site code is applicable.